logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Khoury, Bassim Subhi Farah
    Director born in July 1960
    Individual (3 offsprings)
    Officer
    icon of calendar 2016-05-24 ~ now
    OF - Director → CIF 0
    Mr Bassim Subhi Farah Khoury
    Born in July 1960
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2016-05-24 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Farah, Amin
    Director born in March 1951
    Individual (13 offsprings)
    Officer
    icon of calendar 2016-05-24 ~ now
    OF - Director → CIF 0
    Mr Amin Farah
    Born in March 1951
    Individual (13 offsprings)
    Person with significant control
    icon of calendar 2016-05-24 ~ now
    PE - Has significant influence or controlCIF 0
parent relation
Company in focus

PHARMACARE PREMIUM LIMITED

Standard Industrial Classification
70100 - Activities Of Head Offices
Brief company account
Fixed Assets - Investments
455,605 GBP2025-05-31
455,605 GBP2024-05-31
Cash at bank and in hand
100 GBP2025-05-31
100 GBP2024-05-31
Creditors
Amounts falling due within one year
-994 GBP2025-05-31
-912 GBP2024-05-31
Net Current Assets/Liabilities
-894 GBP2025-05-31
-812 GBP2024-05-31
Total Assets Less Current Liabilities
454,711 GBP2025-05-31
454,793 GBP2024-05-31
Creditors
Amounts falling due after one year
-455,605 GBP2025-05-31
-455,605 GBP2024-05-31
Net Assets/Liabilities
-894 GBP2025-05-31
-812 GBP2024-05-31
Equity
Called up share capital
100 GBP2025-05-31
100 GBP2024-05-31
Retained earnings (accumulated losses)
-994 GBP2025-05-31
-912 GBP2024-05-31
Equity
-894 GBP2025-05-31
-812 GBP2024-05-31
Average Number of Employees
02024-06-01 ~ 2025-05-31
02023-06-01 ~ 2024-05-31
Investments in Group Undertakings
455,605 GBP2025-05-31
455,605 GBP2024-05-31
Amounts owed to group undertakings and participating interests
Amounts falling due within one year
994 GBP2025-05-31
912 GBP2024-05-31

  • PHARMACARE PREMIUM LIMITED
    Info
    Registered number 10196256
    icon of addressInstitute Of Life Sciences Ils 2, Singleton Park, Swansea SA2 8PP
    Private Limited Company incorporated on 2016-05-24 (9 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 26 August 2025 and licensed under the Open Government Licence v3.0.